These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 6259384)

  • 1. Virological study of idiopathic cardiomyopathy: serological study of virus antibodies and immunofluorescent study of myocardial biopsies.
    Kitaura Y
    Jpn Circ J; 1981 Mar; 45(3):279-94. PubMed ID: 6259384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to Coxsackie B viruses in congestive cardiomyopathy.
    Cambridge G; MacArthur CG; Waterson AP; Goodwin JF; Oakley CM
    Br Heart J; 1979 Jun; 41(6):692-6. PubMed ID: 223612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental coxsackie B virus myocarditis in mice: 18 month histopathological and virological study.
    Kutaura Y
    Jpn Circ J; 1981 Jul; 45(7):747-62. PubMed ID: 6267334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Coxsackie B virus antibodies in patients with juvenile dermatomyositis.
    Christensen ML; Pachman LM; Schneiderman R; Patel DC; Friedman JM
    Arthritis Rheum; 1986 Nov; 29(11):1365-70. PubMed ID: 3022759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of Coxsackie B viruses in the etiology of dilated cardiomyopathy].
    Novikov IuI; Stulova MA; Lavrova IK
    Ter Arkh; 1989; 61(11):97-102. PubMed ID: 2561232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coxsackie B infection in a general medical unit.
    Bell EJ; Irvine KG; Gardiner AJ; Rodger JC
    Scott Med J; 1983 Apr; 28(2):157-9. PubMed ID: 6306762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Coxsackie B virus infections in cardiology. Apropos of 66 cases].
    Wattré P; Leroy O; Dewilde A; Thery C
    Pathol Biol (Paris); 1987 Apr; 35(4):347-52. PubMed ID: 3035466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retrospective study of coxsackie B virus infections and congestive cardiomyopathy].
    Campello C; Dal Molin G; Gasparini V; Mestroni L; Salvi A; Camerini F; Majori L
    Boll Ist Sieroter Milan; 1984 Sep; 63(4):325-30. PubMed ID: 6097290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective case-control study of antibodies to coxsackie B virus in idiopathic dilated cardiomyopathy.
    Keeling PJ; Lukaszyk A; Poloniecki J; Caforio AL; Davies MJ; Booth JC; McKenna WJ
    J Am Coll Cardiol; 1994 Mar; 23(3):593-8. PubMed ID: 8113540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 1 diabetes and Coxsackie virus infection.
    Di Pietro C; Del Guercio MJ; Paolino GP; Barbi M; Ferrante P; Chiumello G
    Helv Paediatr Acta; 1979; 34(6):557-61. PubMed ID: 232095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative complement fixation and serum neutralization antibody titers to herpes simplex virus type 1 and Herpesvirus simiae in Macaca mulatta and humans.
    Gary GW; Palmer EL
    J Clin Microbiol; 1977 Apr; 5(4):465-70. PubMed ID: 192762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of the Coxsackie B virus complement fixation test (author's transl)].
    Hofmann H
    Wien Klin Wochenschr; 1975 Dec; 87(24):819-22. PubMed ID: 1226771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coxsackie B virus antibodies in myocardial infarction.
    Nikoskelainen J; Kalliomäki JL; Lapinleimu K; Stenvik M; Halonen PE
    Acta Med Scand; 1983; 214(1):29-32. PubMed ID: 6312770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Coxsackie B virus infection and cardiopathies].
    Santoro R; Rapicetta M; Mancini G; Pietropaolo C
    Boll Ist Sieroter Milan; 1977 Jul; 56(3):282-7. PubMed ID: 901641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dilated cardiomyopathy. An analysis of the viral-immunological theory].
    Aleksandrova LZ; Bakhov NI; Osipov SG; Naumov VG; Titov VN
    Ter Arkh; 1985; 57(4):136-40. PubMed ID: 2990061
    [No Abstract]   [Full Text] [Related]  

  • 16. Neutralizing antibodies against Coxsackie B viruses in patients with recent onset of type I diabetes.
    Mertens T; Grüneklee D; Eggers HJ
    Eur J Pediatr; 1983 Sep; 140(4):293-4. PubMed ID: 6313373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A solid-phase reverse immunosorbent test for the detection of enterovirus IgM.
    Magnius LO; Saleh LH; Vikerfors T; Norder H
    J Virol Methods; 1988 May; 20(1):73-82. PubMed ID: 2840453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of the spontaneous change in serum viral antibody titers in patients with acute Coxsackie B virus myocarditis].
    Feng XM; Pu SY; Yang YZ
    Zhonghua Nei Ke Za Zhi; 1988 Aug; 27(8):466-8, 517-8. PubMed ID: 2851423
    [No Abstract]   [Full Text] [Related]  

  • 19. Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus.
    King ML; Shaikh A; Bidwell D; Voller A; Banatvala JE
    Lancet; 1983 Jun; 1(8339):1397-9. PubMed ID: 6134178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antibodies against Coxsackie B1-6 viruses in type 1 diabetics.
    Alberti AM; Amato C; Candela A; Costantino F; Grandolfo ME; Lombardi F; Novello F; Orsini M; Santoro R
    Acta Diabetol Lat; 1985; 22(1):33-8. PubMed ID: 2988253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.